Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Reexamination Certificate
2005-07-15
2011-11-22
Anderson, James D (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
Reexamination Certificate
active
08063109
ABSTRACT:
Formulations are provided for parenteral administration of (amino substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones and the sodium and potassium salts thereof for the prevention and/or treatment of conditions mediated by abnormal cell proliferation. Composition for parenteral administration are provided which comprise an effective amount of compound of formula Ior a compound of formula IIaand at least about 50% by weight of at least one water soluble polymer selected from the group consisting essentially of polyethylene glycol (PEG), poly-oxyethylene, poly-oxyethylene-poly-oxypropylene copolymers, polyglycerol, polyvinylalcohol, polyvinylpyrrolidone (PVP), polyvinylpyridine N-oxide, copolymer of vinylpyridine N-oxide and vinylpyridine.
REFERENCES:
patent: 4727063 (1988-02-01), Naggi et al.
patent: 4767604 (1988-08-01), Owen et al.
patent: 4834985 (1989-05-01), Elger et al.
patent: 6656973 (2003-12-01), Cosenza et al.
patent: 6667346 (2003-12-01), Reddy et al.
patent: 7598232 (2009-10-01), Reddy et al.
patent: 2010/0152096 (2010-06-01), Bell et al.
patent: WO 03/072062 (2003-09-01), None
patent: WO 2006/010152 (2006-01-01), None
patent: WO 2007/016201 (2007-02-01), None
Reddy et al. Synthesis of alpha beta Unsaturated Sulfones, Acta. Chim. Hung. 115:269-71 (1984).
Reddy et al. Synthesis and Cycloproponation of (E) and (Z)-Styryl Benzyl Sulfones, Sulfur Letters 13:83-90 (1991).
Reddy et al. A Novel synthesis of (E)-Substituted Styryl (Z)-Styryl Sulfones Synthesis No. 4, 322-23 (1984).
Reddy et al. A Pacil Method for the Synthesis of 2-(ArylsulfonyI)-1-Phenyl-3-Aryl-2-Propene-1-Ones, Sulfur Letters 7:43-48 (1987).
Supp EP Search, Dec. 7, 2009, Onconova.
Int Search Report, Jul. 17, 2006, Onconova.
Dash S K et al.: “Preformulation development of a parenteral formulation for ON 01210.Na, a radioprotectant” AAPS Annual Meeting and Exposition,(Online] Nov. 5, 2005-Nov. 10, 2005 pp. 1-1, XP002549966.
Alfieri A A et al: “Radiation damage protection by the benzylstyrl sulfone analog, Ex-Rad” International Journal of Radiation Oncology Biology Physics, vol. 60, No. 1, Suppl. 5,2004, pp. S367.S368, XP002549965 & 46th Annual Meeting of the American Societyfortherapeutic..Radiology and—Oncology; Atlanta.
Strickley et al: “Solubilizing Exipients in Oral and Injectable Formulations” Pharmaceutical Research, Kluwer Academic Publishers, New York, NY, US vol. 21, No. 2, Feb. 1, 2004, p. 201-230.
Bell Stanley C.
Maniar Manoj
Wong Albert
Anderson James D
Khalilian Houri
Law Offices of Khalilian Sira, LLP
Onconova Therapeutics Inc.
LandOfFree
Formulations for parenteral administration of (e)-2,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulations for parenteral administration of (e)-2,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulations for parenteral administration of (e)-2,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268683